Table 5: Findings in PE-Patients.

Age

Sex

Death

localisation

Infiltrate and relevant finding

Symptomatic

Heparin doses

(duration)

Antiaggregation

RHS

D-Dimer before CT scan

DVT

Oncological

Corticoid

Obesity

Previous VTE

86

F

Y

Bilateral central

Severe

Respiratory

insufficiency

Therapeutic (16d)

None

 

1500-4000

N

N

Y

N

N

62

M

N

Bilateral central lobar

None

None

None

None

 

> 4000

N

N

N

N

N

88

F

N

Small

subsegmental

None

None

None

Apixaban

 

 

N

Y

N

Y

N

56

F

N

Small subsegmental

Severe

Dyspnoea

Therapeutic (1d)

None

 

1500-4000

N

N

N

Y

N

77

M

Y

Small subsegmental

Severe

Respiratory

insufficiency

Therapeutic

(25d)

None

 

1500-4000

N

N

Y

N

N

75

M

N

Central unilateral

Mild

None

None

Aspirin

 

 

N

Y

N

N

N

68

F

N

Small subsegmental

Mild,

pericardiac effusion

Dyspnoea

None

None

 

500-1500

N

N

N

Y

N

55

F

N

Bilateral central

Severe

Respiratory insufficiency

Therapeutic doses (2d)

None

 

> 4000

N

N

N

Y

Y

65

F

N

Central unilateral

Mild,

emphysema

Respiratory

insufficiency

Therapeutic (67d)

None

Y

1500 -4000

Y

N

Y

Y

Y